Jean-Claude Kyrillos - 15 Jul 2024 Form 4 Insider Report for TANDEM DIABETES CARE INC (TNDM)

Role
EVP & Chief Operating Officer
Signature
/s/ Rachel Malina, Attorney-in-Fact for Jean-Claude Kyrillos
Issuer symbol
TNDM
Transactions as of
15 Jul 2024
Net transactions value
$0
Form type
4
Filing time
17 Jul 2024, 16:16:51 UTC
Previous filing
26 Jun 2024
Next filing
11 Mar 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNDM Restricted Stock Unit Award $0 +43,634 $0.000000 43,634 15 Jul 2024 Common Stock 43,634 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Awarded on July 15, 2024 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan (the 2023 Plan).
F2 Restricted stock units (RSU) vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 7/15/2025, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.